140 related articles for article (PubMed ID: 35980060)
1. Is There a Relation between Hypothyroidism and Polycystic Ovary Syndrome and its Metabolic Components?
Bonakdaran S; Milani N; Khorasani ZM; Hosseinzadeh M; Kabiri M
Curr Diabetes Rev; 2023; 19(2):e260422204034. PubMed ID: 35980060
[TBL] [Abstract][Full Text] [Related]
2. Impact of elevated thyroid-stimulating hormone levels in polycystic ovary syndrome.
Trummer C; Schwetz V; Giuliani A; Obermayer-Pietsch B; Lerchbaum E
Gynecol Endocrinol; 2015 Oct; 31(10):819-23. PubMed ID: 26190535
[TBL] [Abstract][Full Text] [Related]
3. Clinical, Hormonal, and Metabolic Parameters in Women with Subclinical Hypothyroidism and Polycystic Ovary Syndrome: A Cross-Sectional Study.
Bedaiwy MA; Abdel-Rahman MY; Tan J; AbdelHafez FF; Abdelkareem AO; Henry D; Lisonkova S; Hurd WW; Liu JH
J Womens Health (Larchmt); 2018 May; 27(5):659-664. PubMed ID: 29620956
[TBL] [Abstract][Full Text] [Related]
4. [Subclinical hypothyroidism and endocrine metabolic characteristics in women with polycystic ovary syndrome].
Yue F; Zhang D; Gong F; Zhang L; Sun Z; Lei M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 42(8):940-946. PubMed ID: 28872086
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
Wang L; Lv S; Li F; Yu X; Bai E; Yang X
Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
[No Abstract] [Full Text] [Related]
6. The effect of subclinical hypothyroidism on hormonal and metabolic profiles and ovarian morphology in patients with polycystic ovary syndrome: a cross-sectional study.
Shi D; Du J; Kang H; Feng L; Liu F
Gynecol Endocrinol; 2024 Dec; 40(1):2358219. PubMed ID: 38835150
[TBL] [Abstract][Full Text] [Related]
7. Subclinical hypothyroidism in young women with polycystic ovary syndrome: an analysis of clinical, hormonal, and metabolic parameters.
Benetti-Pinto CL; Berini Piccolo VR; Garmes HM; Teatin Juliato CR
Fertil Steril; 2013 Feb; 99(2):588-92. PubMed ID: 23103018
[TBL] [Abstract][Full Text] [Related]
8. Studies of cardiovascular risk factors in polycystic ovary syndrome patients combined with subclinical hypothyroidism.
Pei YJ; Wang AM; Zhao Y; Yan L; Li M; White RE; Han GC
Gynecol Endocrinol; 2014 Aug; 30(8):553-6. PubMed ID: 24884959
[TBL] [Abstract][Full Text] [Related]
9. Associations between metabolic syndrome, serum thyrotropin, and thyroid antibodies status in postmenopausal women, and the role of interleukin-6.
Siemińska L; Wojciechowska C; Walczak K; Borowski A; Marek B; Nowak M; Kajdaniuk D; Foltyn W; Kos-Kudła B
Endokrynol Pol; 2015; 66(5):394-403. PubMed ID: 26457493
[TBL] [Abstract][Full Text] [Related]
10. Subclinical hypothyroidism is not a risk factor for polycystic ovary syndrome in obese women of reproductive age.
Zhang B; Wang J; Shen S; Liu J; Sun J; Gu T; Zhu D; Bi Y
Gynecol Endocrinol; 2018 Oct; 34(10):875-879. PubMed ID: 29658805
[TBL] [Abstract][Full Text] [Related]
11. The relationship between thyroid function and metabolic changes in Chinese women with polycystic ovary syndrome.
Yin D; Ruan X; Tian X; Du J; Zhao Y; Cui Y; Li Y; Mueck AO
Gynecol Endocrinol; 2017 Apr; 33(4):332-335. PubMed ID: 28051891
[TBL] [Abstract][Full Text] [Related]
12. Dyslipidemia in relation to body mass index and insulin resistance in Chinese women with polycystic ovary syndrome.
Hong Y; Yang D; Liu W; Zhao X; Chen X; Li L
J Biol Regul Homeost Agents; 2011; 25(3):365-74. PubMed ID: 22023761
[TBL] [Abstract][Full Text] [Related]
13. Is subclinical hypothyroidism contributing dyslipidemia and insulin resistance in women with polycystic ovary syndrome?
Celik C; Abali R; Tasdemir N; Guzel S; Yuksel A; Aksu E; Yılmaz M
Gynecol Endocrinol; 2012 Aug; 28(8):615-8. PubMed ID: 22329744
[TBL] [Abstract][Full Text] [Related]
14. Alterations in thyroid function among the different polycystic ovary syndrome phenotypes.
Morgante G; Musacchio MC; Orvieto R; Massaro MG; De Leo V
Gynecol Endocrinol; 2013 Nov; 29(11):967-9. PubMed ID: 23957782
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of polycystic ovary syndrome in women in China: a large community-based study.
Li R; Zhang Q; Yang D; Li S; Lu S; Wu X; Wei Z; Song X; Wang X; Fu S; Lin J; Zhu Y; Jiang Y; Feng HL; Qiao J
Hum Reprod; 2013 Sep; 28(9):2562-9. PubMed ID: 23814096
[TBL] [Abstract][Full Text] [Related]
16. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
[TBL] [Abstract][Full Text] [Related]
17. Subclinical Hypothyroidism in PCOS: Impact on Presentation, Insulin Resistance, and Cardiovascular Risk.
Yu Q; Wang JB
Biomed Res Int; 2016; 2016():2067087. PubMed ID: 27478827
[TBL] [Abstract][Full Text] [Related]
18. Value of the triglyceride-glucose index and non-traditional blood lipid parameters in predicting metabolic syndrome in women with polycystic ovary syndrome.
Zhang L; Wang H; Ma Q; Liu Y; Chen A; Lu J; Ren L
Hormones (Athens); 2023 Jun; 22(2):263-271. PubMed ID: 36790635
[TBL] [Abstract][Full Text] [Related]
19. Subclinical hypothyroidism does not influence the metabolic and hormonal profile of women with PCOS.
Trakakis E; Pergialiotis V; Hatziagelaki E; Panagopoulos P; Salloum I; Papantoniou N
Horm Mol Biol Clin Investig; 2017 Jun; 31(3):. PubMed ID: 28672734
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
